The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Agreed. Hospital resources all over the world being strained. IV iron has got to be down graded in importance due to the response to Covid. But these patients will still need their Fe levels maintaining. Ideal for Feraccru to establish itself in the market , not just in the massive US market, but worldwide.
To be half the price we were on FDA approval is a joke. I suppose it will only be seen as a joke when this is 250/300.
Some facts re Director dealings ...
Sep 18.Chairman 46,000 shares @ 81.5 and 4000 @ 81.0
Apr 19. Chief Medical Officer 22,875 @ 87.4
Apr 19. Wife of above 22,042 @ 90.7
Aug 19. Chairman 75,000 @ 178
Yes. The Chairman had enough confidence just 6 months ago to buy 75,000 at more than double today’s price !!!
And STX are in a better position now , with the cash provided by ASK , US deal around the corner, IV Iron looking a bad alternative when new hospitals are having to be built, China unlocked potential to provide a population over a billion.
DYOR as always
The more this keeps rising , I suppose the more pressure on people to buy back in after the ridiculous over sell off.
But a nice slow sustainable rise will do me until the big news starts flowing from the U.S hopefully.
Having just read below ( which has no relevance to the restrictions of the IV procedure.. the point I was making), it really is good at showing the size of the market that Shield can take from Ferinject etc.
Great stuff. GLAH. DYOR.
https://www.pat.nhs.uk/downloads/patient-information-leaflets/blood/814%20Intravenous%20Iron.pdf
I was highlighting the procedure !!!!!!!!!!! Can find you a more recent one that will be exactly the same if you want ?
And I stated no connection. As there isn’t any.
1. States the IV procedure ( I didn’t even check the date. The procedure is as it is. )
2. States a woman’s story highlighting the cost and ulterior motives of IV Iron
Sorry to spoil your evening.
????
https://www.uhb.nhs.uk/Downloads/pdf/PiIntravenousIron.pdf
Yep , I think Shield are onto something ......
The above or a tablet hmmmmmmmm !?
Maybe Andle. I just think everyone is realising that IV iron replacement , in the current climate of lockdown in most countries and lack of hospital beds and resources means Ferracru is in prime position as a safe and effective replacement for IV. US companies must be chomping at the bit to get this distributed, as hospital resources could be limited for months or years playing catch up with Covid 19